+14%

est. 2Y upside i

E-CommerceHealthcareSeries A

Rank

#1747

Sector

E-commerce / D2C Fitness, Wellness & Athleisure

Est. Liquidity

~2Y

Data Quality

Data: Medium

Boldfit offers a high-risk, moderate-expected-return equity opportunity at ~14% over 2 years.

Last updated: July 3, 2026

Bull (30%)+160%

IPO window and premium brand positioning (IPL partnerships) sustain high multiple around 8x, yielding $336M exit value. 20% dilution reduces net upside to 160%.

Base (25%)-15%

Growth slows and multiple compresses to ~3x in line with public comps, yielding $126M exit. Dilution of 20% results in -15% return.

Bear (45%)-68%

Intense competition from incumbents (Nike, Puma, Decathlon) compresses multiple to 1.5x, exit at $63M. Dilution adds to loss, common down -67.5%.

Est. time to liquidity~2.0 years

Preference Stack Risk

high

Funding Intensity

18%

Total preferred funding of $21.6M equals 18% of current $120M valuation, creating a high preference overhang.

Dilution Risk

high

The planned $80-100M raise could dilute existing shareholders by 40-50%, but we assume 20% dilution from current grant over 2 years.

Secondary Liquidity

none

No secondary market available for this private Indian company.

Questions to Ask at the Interview

Strategic questions based on Boldfit's data — designed to show you've done your homework.

  • 1

    “How does Boldfit plan to defend against Decathlon and Nike in the athleisure space?”

  • 2

    “What is the unit economics and payback period for Boldfit's D2C model?”

  • 3

    “Given the planned $80-100M raise, what is the implied valuation and dilution for new hires?”

Community

Valuation Sentiment

Our model estimates +14% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.